Discover
IBO
Impact BioMedical Inc.
0.48
100 x undefined
800 x undefined
bid
ask
+
0.02
5.22%
450 @ 04:00 PM
0.46 -0.02 (4.26%)
| Ytd | -4.16% | |
| 1y | -24.73% |
0.47
day range
0.50
0.37
52 week range
0.83
| Open | 0.50 | Prev Close | 0.46 | Low | 0.47 | High | 0.50 | Mkt Cap | 52.19M |
| Vol | 170.91K | Avg Vol | 86.60K | EPS | -0.29 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | 0.06 | Inst. Own | 1.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.57 | 200-d Avg | 0.55 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 7.00K | ||
| Revenues (USD) | 7.00K | ||
| Gross Profit | 7.00K | ||
| Operating Expenses | 2.30M | ||
| Research and Development Expense | 46.00K | ||
| Selling, General and Administrative Expense | 1.64M | ||
| Operating Income | -2.29M | ||
| Net Income | -2.29M | ||
| Net Income Common Stock | -2.29M | ||
| Net Income Common Stock (USD) | -2.29M | ||
| Consolidated Income | -2.28M | ||
| Net Income to Non-Controlling Interests | 3.00K | ||
| Earnings per Basic Share | -0.02 | ||
| Earnings per Basic Share (USD) | -0.02 | ||
| Earnings per Diluted Share | -0.02 | ||
| Earning Before Interest & Taxes (EBIT) | -2.29M | ||
| Earning Before Interest & Taxes (USD) | -2.29M | ||
| Weighted Average Shares | 107.79M | ||
| Weighted Average Shares Diluted | 107.79M | ||
| Balance Sheet | |||
| Cash and Equivalents | 20.00K | ||
| Cash and Equivalents (USD) | 20.00K | ||
| Investments | 199.00K | ||
| Investments Current | 199.00K | ||
| Current Assets | 377.00K | ||
| Total Assets | 17.09M | ||
| Current Liabilities | 1.69M | ||
| Total Liabilities | 2.38M | ||
| Accumulated Retained Earnings (Deficit) | -51.79M | ||
| Shareholders Equity | 11.46M | ||
| Shareholders Equity (USD) | 11.46M | ||
| Assets Non-Current | 16.71M | ||
| Goodwill and Intangible Assets | 16.71M | ||
| Inventory | 63.00K | ||
| Liabilities Non-Current | 688.00K | ||
| Trade and Non-Trade Payables | 1.48M | ||
| Tax Liabilities | 688.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 285.00K | ||
| Net Cash Flow from Financing | 482.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 17.00K | ||
| Issuance (Repayment) of Debt Securities | 482.00K | ||
| Net Cash Flow from Investing | -1000 | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -1000 | ||
| Net Cash Flow from Operations | -464.00K | ||
| Share Based Compensation | 1.44M | ||